admin3

Company Remains on Track to Complete $1 Million in Financing in Q1 2014 TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”)announced today it has closed the second tranche of its previously announced private placement equity financing. Under the financing, the Company issued 2,648,000 units at a price of $0.0675 per … Read more

Company Plans to Complete $1 Million in Financing in Q1 2014 TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) announced today it had closed the first tranche of its previously announced private placement equity financing. Under the financing, the Company issued $1,622,222 units at a price of $0.0675 per unit, … Read more

Completion of final milestone triggers a third payment and removal of non-completion penalties Toronto, Canada  – CardioComm Solutions, Inc. ( TSX-V:EKG) (“CardioComm Solutions” or the “Company”)today announced it has completed the final milestone of a software and source code licensing agreement (“SLA”) for use of the Company’s Global ECG Management Solution (“GEMS™”) and GUAVA ECG … Read more

Licensing Deal Signals the Start of Sales of Windows 7 Compatible ECG Software Solutions TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has completed a software and source code licensing agreement (“SLA”) for use of the Company’s proprietary Global ECG Management Solution (“GEMS™”) and GUAVA ECG … Read more

HeartCheck™ Technologies to be used to identify people at risk for potentially life-threatening drug side effects TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has issued an aggregate of 58,141 common shares of the Company to Simi Grosman, a director of the Company. The shares were … Read more

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”)today announced that an aggregate of 567,460 incentive stock options have been granted to two directors of the Company and to a contractor of the Company. The 417,460 options issued to the directors are exercisable at $0.18 per share for five years from … Read more

Ammendment to reflect the new release of GEMS™ WIN as a Windows 7 compatible ECG management software upgrade TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has amended its GEMS™software license agreement (“SLA”) with MD Primer Inc. (“MDP”), which was previously described by the Company in … Read more

Former Executive of ScottCare, CardioNet and Lifewatch Corporation Set to Drive Sales of GEMS? and Mobile Patient Monitoring Solutions into the U.S. Market TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that Mr. Daniel Pawlik has joined the organization as Vice President, Sales and Marketing for the United … Read more

Free cardiac arrhythmia surveillance available at no cost to those with a physician prescription. Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, announced it shall be providing HeartCheck™  SMART Monitoring ECG services at no cost effective December 10, 2013 … Read more

TORONTO, ONTARIO – December 4, 2013. CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that an aggregate of 700,000 incentive stock options have been granted to certain directors of the Company for services rendered in 2013. The options are exercisable … Read more